Four-Drug Combination Effective Long-Term for HIV Suppression Four-Drug Combination Effective Long-Term for HIV Suppression

The single-tablet combination of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) is effective for long-term viral suppression in previously untreated patients with HIV-1 infection, according to 96-week results from the AMBER trial.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Related Links:

Professional societies issue stern warning not to inappropriately prescribe meds for COVID - 19
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
It turns out that many more people than just boomers can benefit from testing for hepatitis C, a viral infection of the liver that often causes no symptoms. If you’re a member of the baby-boom generation (born between 1946 and 1964), your doctor may have already recommended the test. But those born before or after those years may not have known about the test unless they had a risk factor for hepatitis C, such as a history of intravenous drug use. A new guideline is changing this approach. Why the different recommendations for baby boomers? In 2012–2013, the CDC and the US Preventive Services Task Force (USPSTF...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Digestive Disorders Health Infectious diseases Men's Health Sexual Conditions Women's Health Source Type: blogs
WHO backs making pharmaceuticals open up intellectual property as it did to fight HIV/Aids
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
[Monitor] Ministry of Health has suspended the Uganda Population-Based HIV Impact Survey (UPHIA) until further notice following the coronavirus cases in the country.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[Daily Maverick] Covid-19 is real, just as HIV was and remains real. But we should not be foolish, thinking it cannot touch us like we thought HIV could not touch us. HIV did. Covid-19 will. In ways we have yet to imagine. Aids taught us about fear, to overcome it while not being foolish. We need to be afraid of Covid-19, but not of each other.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
BOSTON (CBS) – “I have to call uncle. It’s too much. Too much. I need help,” said I.C.U. nurse Linda Barton. She works at Norwood Hospital and said this past weekend was the busiest and scariest of her career. “This weekend was beyond difficult,” Barton said. “I kept asking and telling them we needed more help. We needed more hands, we needed more R.N.s, we needed more aids.” She said the coronavirus cases were more serious than she expected. “They’re very, very sick. These are people who were living their lives normally two weeks ago, and now are on life-support,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated Local Christina Hager Coronavirus Norwood Hospital Norwood News Source Type: news
Nature Reviews Neurology, Published online: 31 March 2020; doi:10.1038/s41582-020-0352-4Plexin B2 aids wound sealing and healing after spinal cord injury
Source: Nature Reviews Neurology - Category: Neurology Authors: Source Type: research
Source: Therapeutics and Clinical Risk Management - Category: Drugs & Pharmacology Tags: HIV/AIDS - Research and Palliative Care Source Type: research
Authors: Walker SM, Cox E, Revill P, Musiime V, Bwakura-Dangarembizi M, Mallewa J, Cheruiyot P, Maitland K, Ford N, Gibb DM, Walker AS, Soares M, REALITY trial team Abstract INTRODUCTION: Many HIV-positive individuals in Africa have advanced disease when initiating antiretroviral therapy (ART) so have high risks of opportunistic infections and death. The REALITY trial found that an enhanced-prophylaxis package including fluconazole reduced mortality by 27% in individuals starting ART with CD4
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
How consistent are staff who provide community-based HIV testing in their PrEP implementation behaviors?JAIDS: Journal of Acquired Immune Deficiency Syndromes
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
More News: HIV AIDS | Infectious Diseases | Prezista | Truvada | Viread